Kinder, bone mineral homeostasis part II Flashcards

1
Q

what normally makes calcitonin

A

parafolicular cells of the thyroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

principle effects of calcitonin

A

decrease serum Ca and PO4 by actions on bone and kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

calcitonin effects on bone

A

inhibits osteoclastic bone resorption

in time formation reduced as well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

calcitonin effects on kidney

A

dec Ca and PO4 resorption as well as reabsorption of Na K and Mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

therapeutic use of calcitonin

A

disorders of increased skeletal remodeling (pagets and osteoporosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

adverse effects of calcitonin

A

nausea, hand swelling, urticaria, and intestinal cramping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

glucocorticoids actions in bone remodeling

A

antagonize vit D stimulated intestinal Ca transport, stimulate renal Ca excretion and block bone formation
decrease in total body Ca stores

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

therapeutic use of glucocorticoids

A

reversing hyperCa assoc with lymphomas and granulomatous disease like sarcoidosis or in vit D intoxication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

prolonged administration of glucocorticoids can cause what

A

osteoporosis in adults and stunted skel muscle development in children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how do estrogens affect bone

A

prevent accelerated bone loss during the immediate post-menopausal period
transiently increase bone in post menopausal women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how does raloxifene work

A

partial agonist in bone but does not stimulate endometrial proliferation in post menopausal women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

therapeutic use of raloxifene

A

Tx and prevention post menopausal osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

adverse effects of raloxifene

A

hot flashes, leg cramps, thromboembolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

contraindications of raloxifene

A

women with active or pasty history of venous thromboembolism and women with CHD or risk facotrs for major coronary events including stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MOA aldendronate (bisphosphanate)

A

analogs of pyrophosphate in which P-O-P is replaced with non hydrolyzable P-C-P bond

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

where does alendronate concentrate

A

sites of active bone remodeling, incorporated into bone until the bone is remodeled and the bisphosphonate is released back into the acid mdeium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

alendronate effects on osteoclasts

A

directly inhibits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

when should patients take alendronate

A

with full glass of water at least 30 minutes prior to first meal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

therapeutic use of alendronate

A

osteoporosis, hyper Ca, Pagets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

adverse effects of alendronate

A

esophageal and gastric irritation (take with water)

subtrochanteric femur fractures from over suppression of bone turnover

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MOA denosumab

A

monoclonal Ab that prevents action of RANKL by binding it

22
Q

therapeutic use denosumab

A

post-menopausal osteoporosis and some cancers (prostate and breast)

23
Q

how is denosumab administered

A

SQ every 6 mo

24
Q

adverse effects of denosumab

A

increased risk infection because many other cells ahve RANKL
osteonecrosis of jaw and subtrochanteric fractures
can lead to transient hypoCa or comprised Ca regulatory mech like chronic kidney disease and Vit D deficiency

25
signs of hyperCa
CNS depression, coma, death
26
major causes Hyper Ca
thiazie Tx, hyper PTH and cancer
27
less common causes of hyper Ca
hypercitaminosis D, sarcoidosis, thyrotoxicosis, milk alkali syndrome, adrenal insufficiency and immobilization
28
Tx approach to hyper Ca
``` saline diuresis bisphosphonates calcitonin phosphate glucocorticoids ```
29
why is saline diuresis used in hyper Ca
Most patients with severe hypercalcemia have a substantial component of prerenal azotemia due to dehydration which prevents kidney from compensating for the rise in serum calcium by excreting more calcium in the urine.
30
calcitonin use in hyper Ca
Seldom restores calcium to normal but lack of toxicity permits frequent administration at high doses. Effects seen within 4-6 hours, lasts 6-10 hours.
31
phosphate use in hyper Ca
Fastest way to decrease serum calcium but hazardous if not done properly. Give IV phosphates slowly over 6-8 hours and switch to oral products once symptoms clear.
32
Risks associated with IV phosphates
sudden hypocalcemia, ectopic calcification, acute renal failure, hypotension.
33
role of glucocorticoids in hyper Ca
no clear role
34
main features of hypoCa
neuromuscular tetany paresthesias, laryngospasm, muscle cramps, seizures
35
major causes hypoCa
hypoPTH, Vit D def, chronic kidney disease and malabsorption
36
Tx approach to hypoCa
Ca IV, IM PO | VIT D, calcitriol when need rapid action
37
why do we do slow infusions of Ca gluconate in severe hypoCa
to prevent cardiac arrhythmias
38
what is used for IV Ca
Ca gluconate because less irritating to veins than Ca Cl
39
what are the oral formulations fo Ca
Ca carbonate Ca lactate Ca PO4 Ca citrate
40
what is the preferred oral Ca
Ca carbonate because high % of Ca, avaialble, low cost and antacid properties
41
hyperPO4 is a common ocmplicaiton of what
renal failure hypoPTH Vit D intoxication and tumoral calcinosis
42
what is Tx for hyperPO4
dietary restriction and use of PO4-binding gels like sevelamer and Ca supplements
43
what to avoid in hyperPO4
aluminum containing antacids because can cause aluminum assoc bone disease
44
Tx primary hyperPTH
surgery, vit D supp
45
Tx secondary hyperPTH
cinacalcet
46
Tx hypoPTH
Ca and Vit D supp
47
Tx Vit D deficiency
Vit D replacement
48
Tx options for osteoporosis
``` bisphosphonates SERMs Ca and Vit D supp teriparatide calcitonin denosumab ```
49
What is used to Tx Pagets
Calcitonin and bisphosphanates are first line agents
50
Tx with bisphosphanates should not exceed what time period
6 mo, but can be repeated after "holiday" from drug